Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats

Nutrition Research

Volumn 37, Issue , 2017, Pages 37-45

  Kato, Masaki ^a   Nakanishi, Takenori ^a   Tani, Tsubasa ^a   Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

Author keywords

Ca2+ calmodulin dependent kinase II; Glucagon like peptide 1; Intestinal L cells; Rats; Wheat protein hydrolysate

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR FAMILY C GROUP 6 SUBTYPE A; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE RELEASE; HYPERGLYCEMIA; INSULIN RELEASE; L CELL LINE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENTEROENDOCRINE CELL; GLUCOSE INTOLERANCE; METABOLISM; MOLECULAR WEIGHT; MOUSE; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WHEAT;

ANIMALS; BLOOD GLUCOSE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL LINE; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; MALE; MICE; MOLECULAR WEIGHT; PROTEIN HYDROLYSATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRITICUM;

EID: 85005982613     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.12.002     Document Type: Article

References (39)

1. [1] Mojsov, S., Weir, G.C., Habener, J.F., Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79 (1987), 616–619.
2. [2] Kreymann, B., Williams, G., Ghatei, M.A., Bloom, S.R., Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2 (1987), 1300–1304.
3. [3] Buteau, J., Foisy, S., Joly, E., Prentki, M., Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003), 124–132.
4. [4] Drucker, D.J., The biology of incretin hormones. Cell Metab 3 (2006), 153–165.
5. [5] Zander, M., Madsbad, S., Madsen, J.L., Holst, J.J., Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359 (2002), 824–830.
6. [6] Vilsbøll, T., Brock, B., Perrild, H., Levin, K., Lervang, H.H., Kølendorf, K., et al. Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus. Diabet Med 25 (2008), 152–156.
7. [7] Kieffer, T.J., McIntosh, C.H., Pederson, R.A., Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136 (1995), 3585–3596.
8. 2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44 (1995), 1126–1131.
9. [9] Herman, G.A., Bergman, A., Stevens, C., Kotey, P., Yi, B., Zhao, P., et al. A. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab 91 (2006), 4612–4619.
10. [10] Rosenstock, J., Sankoh, S., List, J.F., Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. Diabetes Obes Metab 10 (2008), 376–386.
11. [11] Tsuda, T., Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion. Mol Nutr Food Res 59 (2015), 1264–1273.
12. [12] González-Abuín, N., Martínez-Micaelo, N., Margalef, M., Blay, M., Arola-Arnal, A., Muguerza, B., et al. A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food Funct 5 (2014), 2357–2364.
13. [13] Huang, T.N., KN, L., Pai, Y.P., Chin, H., Huang, C.J., Role of GLP-1 in the hypoglycemic effects of wild bitter gourd. Evid Based Complement Alternat Med, 2013, 2013, 625892.
14. [14] Törrönen, R., Sarkkinen, E., Niskanen, T., Tapola, N., Kilpi, K., Niskanen, L., Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose ingested with berries in healthy subjects. Br J Nutr 107 (2012), 1445–1451.
15. 2+/calmodulin-dependent kinase II activation. Biochem Biophys Res Commun 435 (2013), 165–170.
16. [16] Nagamine, R., Ueno, S., Tsubata, M., Yamaguchi, K., Takagaki, K., Hira, T., et al. Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like peptide-1 (GLP-1). Food Funct 5 (2014), 2309–2316.
17. 2+/calmodulin-dependent kinase II pathway. PLoS One, 10, 2015, e0126157.
18. [18] Higuchi, N., Hira, T., Yamada, N., Hara, H., Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats. Endocrinology 154 (2013), 3089–3098.
19. [19] Reimer, R.A., Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal–regulated kinase1/2 and p38 mitogen-activated protein kinases. J Endocrinol 191 (2006), 159–170.
20. [20] Horiguchi, N., Horiguchi, H., Suzuki, Y., Out-hospital patients with hyperlipidemia and hepatitis with various backgrounds improved by wheat protein hydrolysate (glutamine peptide) administration. Jpn. Pharmacol Ther 32 (2004), 415–420.
21. [21] Horiguchi, N., Horiguchi, H., Suzuki, Y., Effect of wheat gluten hydrolysate on the immune system in healthy human subjects. Biosci Biotechnol Biochem 69 (2005), 2445–2449.
22. [22] Sato, K., Egashira, Y., Ono, S., Mochizuki, S., Shimmura, Y., Suzuki, Y., et al. Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine–induced acute hepatitis in rats. J Agric Food Chem 61 (2013), 6304–6310.
23. 2+ and cAMP. Endocrinology 152 (2011), 405–413.
24. [24] Greenfield, J.R., Farooqi, I.S., Keogh, J.M., Henning, E., Habib, A.M., Blackwood, A., et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr 89 (2009), 106–113.
25. [25] Visser, S., Slangen, C.J., Robben, A., Determination of molecular mass distributions of whey protein hydrolyzates by high-performance size-exclusion chromatography. J Chromat A 599 (1992), 205–209.
26. [26] Drucker, D.J., Jin, T., Asa, S.L., Young, T.A., Brubaker, P.L., Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol 8 (1994), 1646–1655.
27. [27] Mahadev, K., Wu, X., Zilbering, A., Zhu, L., Lawrence, J.T., Goldstein, B.J., Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276 (2001), 48662–48669.
28. [28] Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970), 680–685.
29. [29] Reimann, F., Ward, P.S., Gribble, F.M., Signaling mechanisms underlying the release of glucagon-like peptide 1. Diabetes 55 (2006), S78–S85.
30. 2+/calmodulin-dependent protein kinaseII: the role of structure and autoregulation in cellular function. Ann Rev Biochem 71 (2002), 473–510.
31. [31] Edfalk, S., Steneberg, P., Edlund, H., Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57 (2008), 2280–2287.
32. [32] Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11 (2005), 90–94.
33. [33] Lauffer, L.M., Iakoubov, R., Brubaker, P.L., GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58 (2009), 1058–1066.
34. [34] Janssen, S., Depoortere, I., Nutrient sensing in the gut: new roads to therapeutics?. Trends Endocrinol Metab 24 (2013), 92–100.
35. [35] Oya, M., Kitaguchi, T., Pais, R., Reimann, F., Gribble, F., Tsuboi, T., The G protein-coupled receptor family C group 6 subtype a (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells. J Biol Chem 288 (2013), 4513–4521.
36. [36] Pi, M., Wu, Y., Quarles, L.D., GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo. J Bone Miner Res 26 (2011), 1680–1683.
37. [37] van Loon, L.J.C., Kruijshoop, M., Verhagen, H., Saris, W.H.M., Wagenmakers, A.J.M., Ingestion of protein hydrolysate and amino acid–carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr 130 (2000), 2508–2513.
38. [38] van Loon, L.J.C., Saris, W.H.M., Verhagen, H., Wagenmakers, A.J.M., Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr 72 (2000), 96–105.
39. [39] Rafferty, E.P., Wylie, A.R., Elliott, C.T., Chevallier, O.P., Grieve, D.J., Green, B.D., In vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (GLP-1). Sci Pharm 79 (2011), 615–621.